Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Natalia Baran"'
MaksymowiczMarcela,MachowiecPiotr,BaranNatalia,PiekarskaMałgorzata. The role of soy in development of breast, ovarian, endometrial and prostate gland cancer.Journal of Education, Healthand Sport. 2021;11(9):180-186. eISSN 2391-8306. DOI http://dx.do
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d0845c5be5d22fd4bb26c557c75261
https://zenodo.org/record/5501372
https://zenodo.org/record/5501372
Autor:
Shelley Herbrich, Natalia Baran, Tianyu Cai, Connie Weng, Marisa J L Aitken, Sean M Post, Jared Henderson, Chunhua Shi, Ondrej Havranek, Guillame Richard-Carpentier, Guy Sauvageau, Keith Baggerly, Gheath Al-Atrash, R Eric Davis, Naval Daver, Dongxing Zha, Marina Konopleva
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 7 (2021)
BackgroundAcute myeloid leukemia (AML) stem cells (LSCs) are capable of surviving current standard chemotherapy and are the likely source of deadly, relapsed disease. While stem cell transplant serves as proof-of-principle that AML LSCs can be elimin
Autor:
Katarzyna Tomczak, Katayoun Rezvani, Ken Furudate, Mecit Kaplan, Terzah M. Horton, Helen Ma, Shanti Rojas-Sutterlin, Jiyang Yu, Elias Jabbour, Steven M. Kornblau, Diogo Troggian Veiga, Daniel Herranz, Koichi Takahashi, Jared Henderson, Adolfo A. Ferrando, Yogesh Dhungana, Eric Davis, Trang Hoang, Fieke W Hoff, Alessia Lodi, Anna Skwarska, Shelley M. Herbrich, Maria Emilia Di Francesco, Di Du, Natalia Baran, Stefano Tiziani, Joseph R. Marszalek, Pandey Renu, David T. Teachey, Vivian Ruvolo, Sriram S. Shanmugavelandy, Sujan Piya, Ondrej Havranek, Shannon R. Sweeney, Vinitha Mary Kuruvilla, Philip L. Lorenzi, Ningping Feng, Karine Harutyunyan, Marina Konopleva, Marcin Kamiński, André Haman, Marc O. Warmoes, Mihai Gagea, Michael Andreeff, Jun J. Yang, May Daher, Luciana Melo Garcia, Wentao Yang, Antonio Cavazos
Publikováno v:
Blood. 136:18-20
The inferior cure rate of T-cell acute lymphoblastic leukemia (T-ALL) is associated with inherent drug resistance. The activating NOTCH1 gene mutations have been reported to cause chemoresistance at the stem cell level1. Direct NOTCH1 inhibition has
Autor:
Mayela Mendt, May Daher, Rafet Basar, Mayra Shanley, Bijender Kumar, Francesca Lim Wei Inng, Sunil Acharya, Hila Shaim, Natalie Fowlkes, Jamie P. Tran, Elif Gokdemir, Nadima Uprety, Ana K. Nunez-Cortes, Emily Ensley, Thao Mai, Lucila N. Kerbauy, Luciana Melo-Garcia, Paul Lin, Yifei Shen, Vakul Mohanty, JunJun Lu, Sufang Li, Vandana Nandivada, Jing Wang, Pinaki Banerjee, Francia Reyes-Silva, Enli Liu, Sonny Ang, April Gilbert, Ye Li, Xinhai Wan, Jun Gu, Ming Zhao, Natalia Baran, Luis Muniz-Feliciano, Jeffrey Wilson, Indreshpal Kaur, Mihai Gagea, Marina Konopleva, David Marin, Guilin Tang, Ken Chen, Richard Champlin, Katayoun Rezvani, Elizabeth J. Shpall
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
Acute graft-vs.-host (GVHD) disease remains a common complication of allogeneic stem cell transplantation with very poor outcomes once the disease becomes steroid refractory. Mesenchymal stem cells (MSCs) represent a promising therapeutic approach fo
Autor:
Natalia V. Kirienko, Marina Konopleva, Natalia Baran, S. B. Panina, Fabio Henrique Brasil da Costa
Publikováno v:
Cell Death and Disease, Vol 10, Iss 8, Pp 1-15 (2019)
Cell Death & Disease
Cell Death & Disease
Mitochondria play a central and multifunctional role in the progression of tumorigenesis. Although many recent studies have demonstrated correlations between mitochondrial function and genetic makeup or originating tissue, it remains unclear why some
Autor:
Andrea Santoni, Caleb A. Class, Matteo Pellegrini, Philip L. Lorenzi, Pamela Lockyer, Natalia Baran, Christopher Jackson, Feiyang Ma, Irene Ganan-Gomez, Yun Qing, Jintan Lui, Marina Konopleva, Matteo Marchesini, Min Jin Ha, Lin Tan, Natthakan Thongon, Simona Colla
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S96-S97
Background DNA damage resistance is a major barrier to effective DNA-damaging anticancer therapy in multiple myeloma (MM). To discover novel mechanisms through which MM cells overcome DNA damage, we investigated how MM cells become resistant to antis
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 10782, p 10782 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 10782, p 10782 (2021)
Mutation of the tumor suppressor gene, TP53, is associated with abysmal survival outcomes in acute myeloid leukemia (AML). Although it is the most commonly mutated gene in cancer, its occurrence is observed in only 5–10% of de novo AML, and in 30%
Autor:
Marina Konopleva, Natalia Baran, Eric Davis, Gheath Alatrash, Shelley M. Herbrich, Dongxing Zha
Publikováno v:
Blood. 136:14-15
Background: Acute myeloid leukemia (AML) stem cells (LSC), the likely source of relapsed disease, are capable of surviving current standard chemotherapy. Therefore, novel therapeutic approaches specifically engineered to eradicate LSCs are critical f
Autor:
Alix Derreal, Peter P. Ruvolo, Vinitha M. Kurvilla, Anna Skwarska, Qi Zhang, Michael Andreeff, Sébastien Banquet, Andrew H. Wei, Vivian Ruvolo, Natalia Baran, Paul Panis, Marina Konopleva, Shelley Herbrich, Ensar Halilovic, Donia M Moujalled, Erick Morris
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S220-S221
Autor:
Mien Chie Hung, Antonio Cavazos, Renee Chin, Michael A. Curran, Zhou Jiang, Paul Koller, Natalia Baran, Karine Harutyunyan, Marina Konopleva, Heng Huan Lee, Saradhi Mallampati
Publikováno v:
Blood. 136:44-44
Anti-PD1 therapy in hematologic malignancies has shown clinically inferior effects when compared to solid tumors.1 However, immunotherapy has been part of the standard of care in the treatment of acute leukemia for over 40 years. Recently, loss of MH